Surrozen (SRZN) Change in Cash (2020 - 2026)
Surrozen (SRZN) recorded quarterly Change in Cash of $17.7 million in Q1 2026, up 123.32% quarter-over-quarter from $7.9 million in Q4 2025, and down 73.67% on a YoY basis from $67.1 million in Q1 2025.
Surrozen (SRZN) Change in Cash (2020 - 2026) Analysis & Trends
Surrozen's Change in Cash history runs 7 years deep, the most recent figure standing at $17.7 million for Q1 2026.
- In Q1 2026, Change in Cash fell 73.67% year-over-year to $17.7 million; the TTM figure through Mar 2026 stood at $5.3 million (down 92.92% YoY), while the FY2025 annual figure was $54.7 million, up 3799.59% from the prior year.
- Change in Cash was $17.7 million for Q1 2026 at Surrozen, up from $7.9 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $67.1 million in Q1 2025 to a low of -$18.8 million in Q1 2022.
- Historically, Change in Cash has averaged $4.4 million across 5 years, with a median of $2.6 million in 2022.
- The sharpest annual moves came in 2024 and 2025: Change in Cash plunged 380.63% in 2024, then jumped 866.37% in 2025.
- A 5-year view of Change in Cash shows it stood at -$841000.0 in 2022, then jumped by 377.05% to $2.3 million in 2023, then soared by 52.49% to $3.6 million in 2024, then surged by 122.63% to $7.9 million in 2025, then soared by 123.32% to $17.7 million in 2026.
- The last three Change in Cash figures came in at $17.7 million (Q1 2026), $7.9 million (Q4 2025), and -$9.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 623.00 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -2.44 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 417.10 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -45.97 Mn |
| 10 | Surrozen | 225,877.86 | -106.68 Mn | - | 17.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.67 Mn |
| Dec 31, 2025 | 7.91 Mn |
| Sep 30, 2025 | -9.06 Mn |
| Jun 30, 2025 | -11.26 Mn |
| Mar 31, 2025 | 67.08 Mn |
| Dec 31, 2024 | 3.55 Mn |
| Sep 30, 2024 | -6.75 Mn |
| Jun 30, 2024 | 10.48 Mn |
| Mar 31, 2024 | -8.75 Mn |
| Dec 31, 2023 | 2.33 Mn |
| Sep 30, 2023 | -2.50 Mn |
| Jun 30, 2023 | 8.69 Mn |
| Mar 31, 2023 | 3.12 Mn |
| Dec 31, 2022 | -841,000.00 |
| Sep 30, 2022 | 8.67 Mn |
| Jun 30, 2022 | 2.56 Mn |
| Mar 31, 2022 | -18.79 Mn |
| Dec 31, 2021 | -28.01 Mn |
| Sep 30, 2021 | 42.25 Mn |
| Jun 30, 2021 | -4.55 Mn |